• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤的免疫抑制性肿瘤微环境

Immunosuppressive Tumor Microenvironment of Osteosarcoma.

作者信息

Taylor Aaron Michael, Sheng Jianting, Ng Patrick Kwok Shing, Harder Jeffrey M, Kumar Parveen, Ahn Ju Young, Cao Yuliang, Dzis Alissa M, Jillette Nathaniel L, Goodspeed Andrew, Bodlak Avery, Wu Qian, Isakoff Michael S, George Joshy, Grassmann Jessica D S, Luo Diane, Flynn William F, Courtois Elise T, Robson Paul, Hayashi Masanori, Paolillo Alini Trujillo, Petrilli Antonio Sergio, Caminada de Toledo Silvia Regina, Balarezo Fabiola Sara, Lindsay Adam D, Hoang Bang, Wong Stephen T C, Lau Ching C

机构信息

The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.

Systems Medicine and Bioengineering Department, Houston Methodist Neal Cancer Center, Houston, TX 77030, USA.

出版信息

Cancers (Basel). 2025 Jun 24;17(13):2117. doi: 10.3390/cancers17132117.

DOI:10.3390/cancers17132117
PMID:40647416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12248827/
Abstract

Osteosarcoma is the most common malignant bone tumor in children, characterized by a high degree of genomic instability, resulting in copy number alterations and genomic rearrangements without disease-defining recurrent mutations. Clinical trials based on molecular characterization have failed to find new effective therapies or improve outcomes over the last 40 years. To better understand the immune microenvironment of osteosarcoma, we performed single-cell RNA sequencing on six tumor biopsy samples, combined with a previously published cohort of six samples. Additional osteosarcoma samples were profiled using spatial transcriptomics for the validation of discovered subtypes and to add spatial context. Analysis revealed immunosuppressive cells, including myeloid-derived suppressor cells (MDSCs), regulatory and exhausted T cells, and LAMP3+ dendritic cells. Using cell-cell communication modeling, we identified robust interactions between MDSCs and other cells, leading to NF-κB upregulation and an immunosuppressive microenvironment, as well as interactions involving regulatory T cells and osteosarcoma cells that promoted tumor progression and a proangiogenic niche.

摘要

骨肉瘤是儿童最常见的恶性骨肿瘤,其特征是高度的基因组不稳定,导致拷贝数改变和基因组重排,而无明确疾病的复发性突变。在过去40年中,基于分子特征的临床试验未能找到新的有效疗法或改善治疗结果。为了更好地了解骨肉瘤的免疫微环境,我们对6个肿瘤活检样本进行了单细胞RNA测序,并结合了之前发表的6个样本队列。使用空间转录组学对额外的骨肉瘤样本进行分析,以验证发现的亚型并增加空间背景信息。分析揭示了免疫抑制细胞,包括髓源性抑制细胞(MDSC)、调节性T细胞和耗竭性T细胞,以及LAMP3+树突状细胞。通过细胞间通讯建模,我们确定了MDSC与其他细胞之间的强烈相互作用,导致NF-κB上调和免疫抑制微环境,以及涉及调节性T细胞和骨肉瘤细胞的相互作用,这些相互作用促进了肿瘤进展和促血管生成微环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/470524d05cb5/cancers-17-02117-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/9f39829a389b/cancers-17-02117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/508ce17e86b4/cancers-17-02117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/b76b1b9aebae/cancers-17-02117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/e061e96bc6f9/cancers-17-02117-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/fafba92cf4c9/cancers-17-02117-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/470524d05cb5/cancers-17-02117-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/9f39829a389b/cancers-17-02117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/508ce17e86b4/cancers-17-02117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/b76b1b9aebae/cancers-17-02117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/e061e96bc6f9/cancers-17-02117-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/fafba92cf4c9/cancers-17-02117-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/12248827/470524d05cb5/cancers-17-02117-g006.jpg

相似文献

1
Immunosuppressive Tumor Microenvironment of Osteosarcoma.骨肉瘤的免疫抑制性肿瘤微环境
Cancers (Basel). 2025 Jun 24;17(13):2117. doi: 10.3390/cancers17132117.
2
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
3
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
10
Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review.米法木肽联合标准化疗治疗高级别骨肉瘤的有效性:一项系统评价
JBI Database System Rev Implement Rep. 2017 Aug;15(8):2113-2152. doi: 10.11124/JBISRIR-2016-003105.

本文引用的文献

1
A single-cell and spatially resolved atlas of human osteosarcomas.人类骨肉瘤的单细胞和空间分辨图谱。
J Hematol Oncol. 2024 Aug 20;17(1):71. doi: 10.1186/s13045-024-01598-7.
2
The whole transcriptome analysis using FFPE and fresh tissue samples identifies the molecular fingerprint of osteosarcoma.使用 FFPE 和新鲜组织样本进行全转录组分析可确定骨肉瘤的分子特征。
Exp Biol Med (Maywood). 2024 Jun 20;249:10161. doi: 10.3389/ebm.2024.10161. eCollection 2024.
3
Single-cell transcriptional profiling in osteosarcoma and the effect of neoadjuvant chemotherapy on the tumor microenvironment.
骨肉瘤中的单细胞转录谱分析以及新辅助化疗对肿瘤微环境的影响。
J Bone Oncol. 2024 May 8;46:100604. doi: 10.1016/j.jbo.2024.100604. eCollection 2024 Jun.
4
Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcoma.单细胞和空间转录组学揭示骨肉瘤淋巴结转移机制和微环境重塑。
BMC Med. 2024 May 17;22(1):200. doi: 10.1186/s12916-024-03319-w.
5
Interleukin-1 receptor antagonist: An alternative therapy for cancer treatment.白细胞介素-1 受体拮抗剂:癌症治疗的一种替代疗法。
Life Sci. 2023 Dec 15;335:122276. doi: 10.1016/j.lfs.2023.122276. Epub 2023 Nov 15.
6
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.调控骨肉瘤的免疫微环境:骨肉瘤治疗的前景
Bone Res. 2023 Feb 27;11(1):11. doi: 10.1038/s41413-023-00246-z.
7
Role of tumor microenvironment in cancer progression and therapeutic strategy.肿瘤微环境在癌症进展和治疗策略中的作用。
Cancer Med. 2023 May;12(10):11149-11165. doi: 10.1002/cam4.5698. Epub 2023 Feb 21.
8
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation.内源性白细胞介素 1 受体拮抗剂限制健康和恶性骨髓增殖。
Nat Commun. 2023 Jan 3;14(1):12. doi: 10.1038/s41467-022-35700-9.
9
Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma.在单细胞水平上对肿瘤微环境进行表征揭示了骨肉瘤中一种新的免疫逃逸机制。
Bone Res. 2023 Jan 3;11(1):4. doi: 10.1038/s41413-022-00237-6.
10
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.EGFR 是炎性乳腺癌中免疫抑制和免疫激活肿瘤微环境之间的主开关。
Sci Adv. 2022 Dec 16;8(50):eabn7983. doi: 10.1126/sciadv.abn7983.